Thursday, 27 January 2022

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

Zimmerman lines up new target

Posted 6 December 2021 AM

Hot on the heels of the well-received inquiry into approval proccess for new medicines, the House of Representatives Standing Committee on Health, Aged Care and Sport is conducting another review, this one into childhood rheumatic diseases and juvenile arthritis.

Around one in every thousand children in Australia is affected by juvenile arthritis, and it is more common in girls than boys, according to the Australian Institute of Health and Welfare. The term includes several kinds of arthritis occurring in children, causing significant pain, disability and restrictions in school and other activities.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.